FITC Anti-Human HLA-DR Antibody[L243]

The FITC Anti-Human HLA-DR Antibody [L243] is a highly specific and reliable tool designed for the detection and analysis of human HLA-DR molecules. This antibody, labeled with fluorescein isothiocyanate (FITC), offers exceptional sensitivity and precision in immunofluorescence applications.

The HLA-DR antigen plays a crucial role in the immune response by presenting antigens to T cells, thereby initiating an immune reaction. The FITC Anti-Human HLA-DR Antibody [L243] specifically recognizes the alpha and beta chains of HLA-DR, enabling accurate identification and characterization of HLA-DR-expressing cells.

This antibody has been extensively validated and exhibits minimal cross-reactivity with other HLA-DR isoforms or related molecules. Its high affinity and specificity ensure reliable and reproducible results, making it an ideal choice for research and diagnostic purposes.

The FITC label attached to this antibody allows for direct visualization of HLA-DR expression using fluorescence microscopy or flow cytometry. The bright and stable fluorescence signal emitted by FITC facilitates easy and efficient detection of HLA-DR-positive cells, even at low expression levels.

The FITC Anti-Human HLA-DR Antibody [L243] is supplied as a ready-to-use solution, eliminating the need for time-consuming antibody conjugation procedures. It is provided in a convenient format, ensuring ease of use and reducing experimental variability.

This antibody is manufactured under strict quality control standards to ensure batch-to-batch consistency and optimal performance. It is suitable for a wide range of applications, including immunohistochemistry, immunocytochemistry, and flow cytometry.

In summary, the FITC Anti-Human HLA-DR Antibody [L243] is a highly specific and reliable tool for the detection and analysis of human HLA-DR molecules. Its exceptional sensitivity, specificity, and ease of use make it an invaluable asset for researchers and clinicians in the field of immunology and related disciplines.